586 related articles for article (PubMed ID: 17549300)
1. Hyperresponsiveness of platelets in ischemic stroke.
Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
[TBL] [Abstract][Full Text] [Related]
2. Comment on "hyperresponsiveness of platelets in ischemic stroke" by Fateh-Moghadam et al.
Smout J; Cleanthis M; Stansby G
Thromb Haemost; 2008 Jan; 99(1):239. PubMed ID: 18217162
[No Abstract] [Full Text] [Related]
3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
4. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
[TBL] [Abstract][Full Text] [Related]
5. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
7. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
8. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
Atanassova PA; Chalakova NT; Dimitrov BD
Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
[TBL] [Abstract][Full Text] [Related]
9. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Purdy G; Lawrie AS; Watt H; Brown MM; Machin SJ
Br J Haematol; 2004 Jun; 125(6):777-87. PubMed ID: 15180868
[TBL] [Abstract][Full Text] [Related]
10. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
11. Management and outcome of patients with transient ischemic attack admitted to a stroke unit.
Calvet D; Lamy C; Touzé E; Oppenheim C; Meder JF; Mas JL
Cerebrovasc Dis; 2007; 24(1):80-5. PubMed ID: 17519548
[TBL] [Abstract][Full Text] [Related]
12. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study.
Tobin WO; Kinsella JA; Collins DR; Coughlan T; O'Neill D; Egan B; Tierney S; Feeley TM; Murphy RP; McCabe DJ
Br J Haematol; 2011 Mar; 152(5):640-7. PubMed ID: 21223254
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
[TBL] [Abstract][Full Text] [Related]
14. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack.
McCabe DJ; Harrison P; Sidhu PS; Brown MM; Machin SJ
Br J Haematol; 2004 Sep; 126(6):861-9. PubMed ID: 15352991
[TBL] [Abstract][Full Text] [Related]
15. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke.
Barber M; Morton JJ; Macfarlane PW; Barlow N; Roditi G; Stott DJ
Cerebrovasc Dis; 2007; 23(4):260-6. PubMed ID: 17199083
[TBL] [Abstract][Full Text] [Related]
16. Enhanced platelet activation by prolactin in patients with ischemic stroke.
Wallaschofski H; Lohmann T; Hild E; Kobsar A; Siegemund A; Spilcke-Liss E; Hentschel B; Stumpf C; Daniel WG; Garlichs CD; Eigenthaler M
Thromb Haemost; 2006 Jul; 96(1):38-44. PubMed ID: 16807649
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke.
Cha JK; Jo WS; Shin HC; Bae HR; Ho JM; Kim JW
Platelets; 2004 Feb; 15(1):3-7. PubMed ID: 14985170
[TBL] [Abstract][Full Text] [Related]
18. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
[TBL] [Abstract][Full Text] [Related]
19. The clinical utility of Multiplate analyser measurement in platelet function testing following stroke and transient ischaemic attack.
Mannu GS; Macartney A; Lambert JR; Bettencourt-Silva JH; Lawn M; Lyall H; Metcalf AK; Potter JF; Wood J; Clark A; Baglin T; Myint PK; Bowles KM
Eur J Haematol; 2015 Feb; 94(2):138-44. PubMed ID: 24981148
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack.
Shenhar-Tsarfaty S; Ben Assayag E; Bova I; Shopin L; Fried M; Berliner S; Shapira I; Bornstein NM
Int J Stroke; 2010 Feb; 5(1):16-20. PubMed ID: 20088988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
